53 /100
HIGH RISK
Score updated Jul 14, 2026

NDRA — ENDRA Life Sciences Inc. Dilution Risk Tracker

Track NDRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NDRA — Get alerts when the score changes →

As of July 14, 2026, ENDRA Life Sciences Inc. (NDRA) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. ENDRA Life Sciences Inc. has a market capitalization of $10.17M, 1.27M shares outstanding, 1 institutional holders tracked. Key dilution vectors include 31.7K outstanding warrants, approximately 8 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
💰 Capital Raise 15%
• Under 12 months cash (8mo)
🔔 Track NDRA — Get forecast alerts →

💹 Market Data

Market Cap$10.17M
Shares Outstanding1.27M
Float1.20M
Cash$4.82M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

1 institutional holders · 12.8K shares
#1 Marex Group plc 12.8K shares

📉 Short Interest

Short Interest42.1K
Days to Cover1.0
% of Float3.5%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Mar 04, 2026
4 INSIDER TRANSACTION Mar 04, 2026
4 INSIDER TRANSACTION Jan 23, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NDRA Shareholders

ENDRA Life Sciences Inc. (NDRA) has a DilutionScore of 53/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: NDRA has approximately 8 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for NDRA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NDRA alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NDRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NDRA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NDRA
📊 NDRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NDRA Signal Convergence & Dark Pool Activity — StonkWhisper 📄 NDRA Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.